ACR appropriateness criteria® pretreatment planning of invasive cancer of the cervix

Journal of the American College of Radiology

Volumn 9, Issue 6, 2012, Pages 395-402

  Siegel, Cary Lynn ^a   Andreotti, Rochelle F ^b   Cardenes, Higinia Rosa ^c   Brown, Douglas L ^d   Gaffney, David K ^e   Horowitz, Neil S ^f,g   Javitt, Marcia C ^h   Lee, Susanna I ⁱ   Mitchell, Donald G ^j   Moore, David H ^k,l   Rao, Gautam G ^m,n   Royal, Henry D ^a,o   Small, William ^p   Varia, Mahesh A ^q   Yashar, Catheryn M ^r  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c INDIANA UNIVERSITY MEDICAL CENTER   (United States)

^d MAYO CLINIC   (United States)

^e UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

^f BRIGHAM AND WOMEN S HOSPITAL   (United States)

^g Society of Gynecologic Oncologists   (United States)

^h WALTER REED ARMY MEDICAL CENTER   (United States)

ⁱ MASSACHUSETTS GENERAL HOSPITAL   (United States)

^j THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

^k INDIANA UNIVERSITY   (United States)

^l AMERICAN COLLEGE OF OBSTETRICIANS AND GYNECOLOGISTS   (United States)

^m UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

ⁿ AMERICAN SOCIETY OF CLINICAL ONCOLOGY   (United States)

^o Society of Nuclear Medicine   (United States)

^p NORTHWESTERN UNIVERSITY   (United States)

^q UNIVERSITY OF NORTH CAROLINA HOSPITALS   (United States)

^r UNIVERSITY OF CALIFORNIA   (United States)

more..

Author keywords

Appropriateness Criteria; cervical cancer; imaging; invasive; pretreatment

Indexed keywords

FLUORODEOXYGLUCOSE F 18; TECHNETIUM 99M;

ARTICLE; BARIUM ENEMA; BONE SCINTISCANNING; CANCER CLASSIFICATION; CANCER INVASION; CANCER LOCALIZATION; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; ENDOCYTOSCOPY; HUMAN; INTRAVENOUS UROGRAPHY; LYMPH NODE METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; POSITRON EMISSION TOMOGRAPHY; PRACTICE GUIDELINE; RADIATION DOSE; RECTOSCOPY; THORAX RADIOGRAPHY; TRANSVAGINAL ECHOGRAPHY; TUMOR VOLUME; UTERINE CERVIX CANCER;

EID: 84926231819     PISSN: 15461440     EISSN: 1558349X     Source Type: Journal    
DOI: 10.1016/j.jacr.2012.02.021     Document Type: Review

References (68)

1. National Cancer Institute Comprehensive cancer information http://www.cancer.gov/cancertopics/types/cervical/ Accessed January 13, 2010
2. P.A. Wingo, T. Tong, S. Bolden Cancer statistics 1995 CA Cancer J Clin 45 1995 8 30
3. American Cancer Society Cancer facts and figures 1995 1995 American Cancer Society Atlanta, Ga
4. American Cancer Society Cancer facts and figures 2004 2004 American Cancer Society Atlanta, Ga
5. National Cancer Institute Comprehensive cancer information SEER stat fact sheets: cervix uteri http://seer.cancer.gov/statfacts/html/cervix.html Accessed January 13, 2010
6. F. Pettersson 21st annual report on the result of treatment in gynecological cancer Int J Gynecol Obstet 36 1991 27 130
7. E. Rylander Cervical intraepithelial neoplasia J.J. Kavanaugh, Cancer in women 1998 Blackwell Science Malden, Mass 251 258
8. P.W. Grigsby, B.A. Siegel, F. Dehdashti Lymph node staging by positron emission tomography in patients with carcinoma of the cervix J Clin Oncol 19 2001 3745 3749
9. H. Hricak, J.M. Quivey, Z. Campos Carcinoma of the cervix: predictive value of clinical and magnetic resonance (MR) imaging assessment of prognostic factors Int J Radiat Oncol Biol Phys 27 1993 791 801
10. W.P. Soutter, J. Hanoch, T. D'Arcy, R. Dina, G.A. McIndoe, N.M. DeSouza Pretreatment tumour volume measurement on high-resolution magnetic resonance imaging as a predictor of survival in cervical cancer BJOG 111 2004 741 747
11. W.T. Creasman New gynecologic cancer staging Gynecol Oncol 58 1995 157 158
12. S. Pecorelli Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium Int J Gynaecol Obstet 105 2009 103 104
13. S. Pecorelli, F. Odicino Cervical cancer staging Cancer J 9 2003 390 394
14. M.A. Amendola, H. Hricak, D.G. Mitchell Utilization of diagnostic studies in the pretreatment evaluation of invasive cervical cancer in the United States: results of intergroup protocol ACRIN 6651/GOG 183 J Clin Oncol 23 2005 7454 7459
15. H. Kaur, P.M. Silverman, R.B. Iyer, C.F. Verschraegen, P.J. Eifel, C. Charnsangavej Diagnosis, staging, and surveillance of cervical carcinoma AJR Am J Roentgenol 180 2003 1621 1631
16. A.N. Viswanathan, J. Dimopoulos, C. Kirisits, D. Berger, R. Potter Computed tomography versus magnetic resonance imaging-based contouring in cervical cancer brachytherapy: results of a prospective trial and preliminary guidelines for standardized contours Int J Radiat Oncol Biol Phys 68 2007 491 498
17. Y. Yildirim, S. Sehirali, M.E. Avci Integrated PET/CT for the evaluation of para-aortic nodal metastasis in locally advanced cervical cancer patients with negative conventional CT findings Gynecol Oncol 108 2008 154 159
18. H. Hricak, C. Gatsonis, D.S. Chi Role of imaging in pretreatment evaluation of early invasive cervical cancer: results of the intergroup study American College of Radiology Imaging Network 6651-Gynecologic Oncology Group 183 J Clin Oncol 23 2005 9329 9337
19. D. Fischerova, D. Cibula, H. Stenhova Transrectal ultrasound and magnetic resonance imaging in staging of early cervical cancer Int J Gynecol Cancer 18 2008 766 772
20. C.M. Ho, T.Y. Chien, C.M. Jeng, Y.M. Tsang, B.Y. Shih, S.C. Chang Staging of cervical cancer: comparison between magnetic resonance imaging, computed tomography and pelvic examination under anesthesia J Formos Med Assoc 91 1992 982 990
21. S.H. Kim, B.I. Choi, J.K. Han Preoperative staging of uterine cervical carcinoma: comparison of CT and MRI in 99 patients J Comput Assist Tomogr 17 1993 633 640
22. L.L. Subak, H. Hricak, C.B. Powell, L. Azizi, J.L. Stern Cervical carcinoma: computed tomography and magnetic resonance imaging for preoperative staging Obstet Gynecol 86 1995 43 50
23. H. Hricak, C. Gatsonis, F.V. Coakley Early invasive cervical cancer: CT and MR imaging in preoperative evaluation - ACRIN/GOG comparative study of diagnostic performance and interobserver variability Radiology 245 2007 491 498
24. D.G. Mitchell, B. Snyder, F. Coakley Early invasive cervical cancer: tumor delineation by magnetic resonance imaging, computed tomography, and clinical examination, verified by pathologic results, in the ACRIN 6651/GOG 183 Intergroup Study J Clin Oncol 24 2006 5687 5694
25. M. Bellomi, G. Bonomo, F. Landoni Accuracy of computed tomography and magnetic resonance imaging in the detection of lymph node involvement in cervix carcinoma Eur Radiol 15 2005 2469 2474
26. H.K. Pannu, E.K. Fishman Evaluation of cervical cancer by computed tomography: current status Cancer 98 2003 2039 2043
27. S.H. Choi, S.H. Kim, H.J. Choi, B.K. Park, H.J. Lee Preoperative magnetic resonance imaging staging of uterine cervical carcinoma: results of prospective study J Comput Assist Tomogr 28 2004 620 627
28. K. Narayan, A. McKenzie, R. Fisher, B. Susil, T. Jobling, D. Bernshaw Estimation of tumor volume in cervical cancer by magnetic resonance imaging Am J Clin Oncol 26 2003 e163 e168
29. N.M. deSouza, R. Dina, G.A. McIndoe, W.P. Soutter Cervical cancer: value of an endovaginal coil magnetic resonance imaging technique in detecting small volume disease and assessing parametrial extension Gynecol Oncol 102 2006 80 85
30. S. Bipat, A.S. Glas, J. van der Velden, A.H. Zwinderman, P.M. Bossuyt, J. Stoker Computed tomography and magnetic resonance imaging in staging of uterine cervical carcinoma: a systematic review Gynecol Oncol 91 2003 59 66
31. H.H. Lien, V. Blomlie, T. Iversen, C. Trope, K. Sundfor, V.M. Abeler Clinical stage I carcinoma of the cervix Value of MR imaging in determining invasion into the parametrium Acta Radiol 34 1993 130 132
32. M. Sheu, C. Chang, J. Wang, M. Yen MR staging of clinical stage I and IIa cervical carcinoma: a reappraisal of efficacy and pitfalls Eur J Radiol 38 2001 225 231
33. M. Hori, T. Kim, T. Murakami Uterine cervical carcinoma: preoperative staging with 3.0-T MR imaging - comparison with 1.5-T MR imaging Radiology 251 2009 96 104
34. G.S. Payne, M. Schmidt, V.A. Morgan Evaluation of magnetic resonance diffusion and spectroscopy measurements as predictive biomarkers in stage 1 cervical cancer Gynecol Oncol 116 2010 246 252
35. E.M. Charles-Edwards, C. Messiou, V.A. Morgan Diffusion-weighted imaging in cervical cancer with an endovaginal technique: potential value for improving tumor detection in stage Ia and Ib1 disease Radiology 249 2008 541 550
36. G. Lin, K.C. Ho, J.J. Wang Detection of lymph node metastasis in cervical and uterine cancers by diffusion-weighted magnetic resonance imaging at 3T J Magn Reson Imaging 28 2008 128 135
37. K. Narayan Arguments for a magnetic resonance imaging-assisted FIGO staging system for cervical cancer Int J Gynecol Cancer 15 2005 573 582
38. H.H. Chung, K.W. Kang, J.Y. Cho Role of magnetic resonance imaging and positron emission tomography/computed tomography in preoperative lymph node detection of uterine cervical cancer Am J Obstet Gynecol 203 2010 156.e1 156.e5
39. H.J. Choi, J.W. Roh, S.S. Seo Comparison of the accuracy of magnetic resonance imaging and positron emission tomography/computed tomography in the presurgical detection of lymph node metastases in patients with uterine cervical carcinoma: a prospective study Cancer 106 2006 914 922
40. S. Sironi, F. De Cobelli, G. Scarfone Carcinoma of the cervix: value of plain and gadolinium-enhanced MR imaging in assessing degree of invasiveness Radiology 188 1993 797 801
41. S.K. Kim, H.J. Choi, S.Y. Park Additional value of MR/PET fusion compared with PET/CT in the detection of lymph node metastases in cervical cancer patients Eur J Cancer 45 2009 2103 2109
42. H. Hricak, C.B. Powell, K.K. Yu Invasive cervical carcinoma: role of MR imaging in pretreatment work-up - cost minimization and diagnostic efficacy analysis Radiology 198 1996 403 409
43. J. Scheidler, H. Hricak, K.K. Yu, L. Subak, M.R. Segal Radiological evaluation of lymph node metastases in patients with cervical cancer A meta-analysis JAMA 278 1997 1096 1101
44. P.W. Grigsby The prognostic value of PET and PET/CT in cervical cancer Cancer Imaging 8 2008 146 155
45. L.J. Havrilesky, S.L. Kulasingam, D.B. Matchar, E.R. Myers FDG-PET for management of cervical and ovarian cancer Gynecol Oncol 97 2005 183 191
46. M.J. Reinhardt, C. Ehritt-Braun, D. Vogelgesang Metastatic lymph nodes in patients with cervical cancer: detection with MR imaging and FDG PET Radiology 218 2001 776 782
47. A.J. Hope, P. Saha, P.W. Grigsby FDG-PET in carcinoma of the uterine cervix with endometrial extension Cancer 106 2006 196 200
48. W. Park, Y.J. Park, S.J. Huh The usefulness of MRI and PET imaging for the detection of parametrial involvement and lymph node metastasis in patients with cervical cancer Jpn J Clin Oncol 35 2005 260 264
49. S. Sironi, A. Buda, M. Picchio Lymph node metastasis in patients with clinical early-stage cervical cancer: detection with integrated FDG PET/CT Radiology 238 2006 272 279
50. W.C. Lin, Y.C. Hung, L.S. Yeh, C.H. Kao, R.F. Yen, Y.Y. Shen Usefulness of (18)F-fluorodeoxyglucose positron emission tomography to detect para-aortic lymph nodal metastasis in advanced cervical cancer with negative computed tomography findings Gynecol Oncol 89 2003 73 76
51. D. Allen, K. Narayan Managing advanced-stage cervical cancer Best Pract Res Clin Obstet Gynaecol 19 2005 591 609
52. H.H. Chung, H. Jo, W.J. Kang Clinical impact of integrated PET/CT on the management of suspected cervical cancer recurrence Gynecol Oncol 104 2007 529 534
53. L.J. Havrilesky, T.Z. Wong, A.A. Secord, A. Berchuck, D.L. Clarke-Pearson, E.L. Jones The role of PET scanning in the detection of recurrent cervical cancer Gynecol Oncol 90 2003 186 190
54. S.Y. Ryu, M.H. Kim, S.C. Choi, C.W. Choi, K.H. Lee Detection of early recurrence with 18F-FDG PET in patients with cervical cancer J Nucl Med 44 2003 347 352
55. T.C. Yen, L.C. See, T.C. Chang Defining the priority of using 18F-FDG PET for recurrent cervical cancer J Nucl Med 45 2004 1632 1639
56. T.C. Chang, K.S. Law, J.H. Hong Positron emission tomography for unexplained elevation of serum squamous cell carcinoma antigen levels during follow-up for patients with cervical malignancies: a phase II study Cancer 101 2004 164 171
57. P.W. Grigsby, B.A. Siegel, F. Dehdashti, J. Rader, I. Zoberi Posttherapy [18F] fluorodeoxyglucose positron emission tomography in carcinoma of the cervix: response and outcome J Clin Oncol 22 2004 2167 2171
58. E.A. Kidd, B.A. Siegel, F. Dehdashti Lymph node staging by positron emission tomography in cervical cancer: relationship to prognosis J Clin Oncol 28 2010 2108 2113
59. Y.Y. Lee, C.H. Choi, C.J. Kim The prognostic significance of the SUVmax (maximum standardized uptake value for F-18 fluorodeoxyglucose) of the cervical tumor in PET imaging for early cervical cancer: preliminary results Gynecol Oncol 115 2009 65 68
60. K. Nakamura, Y. Okumura, J. Kodama, A. Hongo, S. Kanazawa, Y. Hiramatsu The predictive value of measurement of SUVmax and SCC-antigen in patients with pretreatment of primary squamous cell carcinoma of cervix Gynecol Oncol 119 2010 81 86
61. M. Yilmaz, M. Adli, Z. Celen, S. Zincirkeser, A. Dirier FDG PET-CT in cervical cancer: relationship between primary tumor FDG uptake and metastatic potential Nucl Med Commun 31 2010 526 531
62. F. Xue, L.L. Lin, F. Dehdashti, T.R. Miller, B.A. Siegel, P.W. Grigsby F-18 fluorodeoxyglucose uptake in primary cervical cancer as an indicator of prognosis after radiation therapy Gynecol Oncol 101 2006 147 151
63. F.Y. Liu, T.C. Yen, M.Y. Chen Detection of hematogenous bone metastasis in cervical cancer: 18F-fluorodeoxyglucose-positron emission tomography versus computed tomography and magnetic resonance imaging Cancer 115 2009 5470 5480
64. T. Ozulker, A. Kucukoz Uzun, F. Ozulker, T. Ozpacac Comparison of (18)F-FDG-PET/CT with (99m)Tc-MDP bone scintigraphy for the detection of bone metastases in cancer patients Nucl Med Commun 31 2010 597 603
65. G. Koliopoulos, A. Sotiriadis, M. Kyrgiou, P. Martin-Hirsch, G. Makrydimas, E. Paraskevaidis Conservative surgical methods for FIGO stage IA2 squamous cervical carcinoma and their role in preserving women's fertility Gynecol Oncol 93 2004 469 473
66. P.D. Peppercorn, A.R. Jeyarajah, R. Woolas Role of MR imaging in the selection of patients with early cervical carcinoma for fertility-preserving surgery: initial experience Radiology 212 1999 395 399
67. American College of Radiology Manual on contrast media v7 http://www.acr.org/SecondaryMainMenuCategories/quality-safety/contrast-manual. aspx Accessed April 4, 2012
68. ®: radiation dose assessment introduction http://www.acr.org/ SecondaryMainMenuCategories/quality-safety/app-criteria/RRLInformation.aspx Accessed February 17, 2011